X

Get started with SANeForce

The paradigm shift from traditional detailing is must

The paradigm shift from traditional detailing is must!!

Multipurpose
With our most enthralling modes of detailing and sales force automation namely e-Detailing, Closed Loop Marketing [CLM], Remote Detailing along with the extra ordinary features it has.

“Market in the Year you live in” is cent percent agreed statement by Gary Vaynerchuk. But still most Pharma Companies skeptic on moving to a digital transformation. From an IQVIA survey, 36% of doctors haven't heard from pharma companies in the last two months, and 77% of doctors believe it's critical to keep in touch with pharma companies during COVID-19.

This eventually indicates that doctors are interested in maintaining contact with pharmaceutical companies, providing a rare opportunity for the pharmaceutical marketing segment to thrive on the Corona crisis. The Covid-19 crisis spurred pharma companies to innovate, and they began rethinking their current approaches to reaching out to doctors and conducting face-to-face meetings. The accelerating digital sales trend, fuelled by constraints imposed on physician clinic visits, appears to be headed for a permanent shift to digital detailing.

It also provides plethora of opportunities for sales reps to brush up on their expertise, hold meetings to find gaps in advertising strategies, and optimize customer experience management with the help of intelligent SAN Pharma SFA software. Pharma companies will fill the gap in physicians' aspirations, which have been unmet for decades, by going beyond work duties optimization.

Overview glance at the HCP’s expectations to have since the outbreak of Covid-19 till the aftermath of the crisis.

  • E-Detailing – Closed Loop Marketing [CLM]
  • Remote Detailing
  • Being specific on HCP engagement
  • Active Personalized Interaction
  • Most co-ordinating campaigns
  • E-Detailing – Closed Loop Marketing [CLM]

    The process becomes more immersive when visual media is used to demonstrate the product and its functionality. The bright slides are sure to attract the doctors' attention. E-detailing applications have a built-in tracking function that records the amount of time a user spends on each slide, providing insight into the user's interest in each product. Users may also provide input in the form of ratings and comments through CLM applications. With the click of a button, any new slides containing product information can be easily imported onto the device. The time spent discussing a product through an e-detailing framework is significantly less than the time spent explaining the products or using traditional methods.

    Remote Detailing

    This is actually a boon to all the Pharma Companies in this particular circumstances. The most intuitive e-detailing platform where the Medical Rep is enables to consistently provide impactful calls. This brings HCP’s closer to gather valuable customer data and collaborate efficiently. Its easier than ever to give interactive and visually engaging presentations to gain valuable insights from your analytics, to edit update and optimize slides. So you can exactly get what and when they need it. It only allows you to share content that has been authorized, has great navigation, works on all devices, and doesn't need any plugins! It's the most effective way to associate pharmaceutical and medical sales reps with health-care practitioners over the internet.

    Being specific on HCP engagement

    It's impossible to determine when pharmaceutical companies will resume their pre-crisis engagement and support activities. The path will be extremely uneven, based on changes in HCP guidelines, needs, and expectations, as well as changes in local government guidelines, needs, and expectations. It all comes down to the future. HCPs are no longer interested in receiving standardised messages as part of a generic marketing effort; instead, they prefer customised system efficiency tailored to their specific needs.

    Active Personalized Interaction

    It's impossible to determine when pharmaceutical companies will resume their pre-crisis engagement and support activities. The path will be extremely uneven, based on changes in HCP guidelines, needs, and expectations, as well as changes in local government guidelines, needs, and expectations. It all comes down to the future. HCPs are no longer interested in receiving standardised messages as part of a generic marketing effort; instead, they prefer customised system efficiency tailored to their specific needs.

    Most coordinating campaigns

    HCPs have seen three or four reps waiting for their turn to finish a meeting prior to the pandemic. Owing to high occupancy, it was difficult for the HCPs to accommodate the number of reps in a day. The bombardment of messages should not be present when the situation is replaced digitally because it is daunting. The HCPs either ignore the messages or discourage the reps from sending them by blocking them.